[HTML][HTML] PET imaging of neuroinflammation in Alzheimer's disease
R Zhou, B Ji, Y Kong, L Qin, W Ren, Y Guan… - Frontiers in …, 2021 - frontiersin.org
Neuroinflammation play an important role in Alzheimer's disease pathogenesis. Advances in
molecular imaging using positron emission tomography have provided insights into the time …
molecular imaging using positron emission tomography have provided insights into the time …
Epilepsy and epileptiform activity in late-onset Alzheimer disease: Clinical and pathophysiological advances, gaps and conundrums
A Kamondi, M Grigg-Damberger, W Löscher… - Nature Reviews …, 2024 - nature.com
A growing body of evidence has demonstrated a link between Alzheimer disease (AD) and
epilepsy. Late-onset epilepsy and epileptiform activity can precede cognitive deterioration in …
epilepsy. Late-onset epilepsy and epileptiform activity can precede cognitive deterioration in …
[HTML][HTML] Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of …
Y Kong, CA Maschio, X Shi, F Xie, C Zuo… - Molecular …, 2024 - Springer
Reactive astrocytes play an important role in the development of Alzheimer's disease (AD).
Here, we aimed to investigate the temporospatial relationships among monoamine oxidase …
Here, we aimed to investigate the temporospatial relationships among monoamine oxidase …
[HTML][HTML] Reduced SV2A and GABAA receptor levels in the brains of type 2 diabetic rats revealed by [18F] SDM-8 and [18F] flumazenil PET
Purpose Type 2 diabetes mellitus (T2DM) is associated with a greater risk of Alzheimer's
disease. Synaptic impairment and protein aggregates have been reported in the brains of …
disease. Synaptic impairment and protein aggregates have been reported in the brains of …
[HTML][HTML] Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
M Robbins - Neural Regeneration Research, 2023 - journals.lww.com
Advances in experimental and computational technologies continue to grow rapidly to
provide novel avenues for the treatment of neurodegenerative disorders. Despite this, there …
provide novel avenues for the treatment of neurodegenerative disorders. Despite this, there …
The HOPE4MCI study: A randomized doubleblind assessment of AGB101 for the treatment of MCI due to AD
INTRODUCTION In addition to the accumulation of amyloid plaques and neurofibrillary
tangles, the presence of excess neural activity is a pathological hallmark of Alzheimer's …
tangles, the presence of excess neural activity is a pathological hallmark of Alzheimer's …
Early preclinical plasma protein biomarkers of brain trauma are influenced by early seizures and levetiracetam
PG Saletti, WB Mowrey, W Liu, Q Li… - Epilepsia …, 2023 - Wiley Online Library
Objective We used the lateral fluid percussion injury (LFPI) model of moderatetosevere
traumatic brain injury (TBI) to identify early plasma biomarkers predicting injury, early post …
traumatic brain injury (TBI) to identify early plasma biomarkers predicting injury, early post …
[HTML][HTML] Positron emission tomography in animal models of Alzheimer's disease amyloidosis: translational implications
R Ni - Pharmaceuticals, 2021 - mdpi.com
Animal models of Alzheimer's disease amyloidosis that recapitulate cerebral amyloid-beta
pathology have been widely used in preclinical research and have greatly enabled the …
pathology have been widely used in preclinical research and have greatly enabled the …
[HTML][HTML] Dynamin-like protein 1 (DNML1) as a molecular target for antibody-based immunotherapy to treat glaucoma
H Tonner, S Hunn, N Auler, C Schmelter… - International journal of …, 2022 - mdpi.com
Slow and progressive loss of retinal ganglion cells (RGCs) is the main characteristic of
glaucoma, the second leading cause of blindness worldwide. Previous studies have shown …
glaucoma, the second leading cause of blindness worldwide. Previous studies have shown …
[HTML][HTML] Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery
Y Zhang, L Heylen, M Partoens, JD Mills… - Frontiers in Molecular …, 2022 - frontiersin.org
Synaptic vesicle glycoprotein 2A (SV2A) regulates action potential-dependent
neurotransmitter release and is commonly known as the primary binding site of an approved …
neurotransmitter release and is commonly known as the primary binding site of an approved …